Skip to main content
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

Jeffrey P. Struewing, M.D.

Jeff Struewing
Program Director
Genotype-Tissue Expression Project (GTEx)

Division of Genomic Medicine

M.D. Indiana University, 1985
M.S. University of Maryland, 1988

T: (301) 480-3435
F: (301) 480-2770
Room 4076, MSC 9305
ROCKVILLE, MD 20892-9305

Genotype-Tissue Expression Project

Dr Struewing is a Program Director in the Division of Extramural Research at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).

Dr. Struewing joined the NIH in 1991, following three years as a U.S. Navy Medical Officer in San Diego. His interdisciplinary studies have focused on inherited factors in cancer, particularly breast and ovarian cancer, first in the Genetic Epidemiology Branch and then in the Laboratory of Population Genetics at the National Cancer Institute (NCI), where he received tenure in 2001.

In 2007, Dr. Struewing joined the Office of Population Genomics at NHGRI and moved to the Division of Extramural Research in 2009, where he serves as a Program Director. He is the Program Coordinator for the Genotype-Tissue Expression Project of the NIH Common Fund.

Dr. Struewing received his M.D. in 1985 from Indiana University School of Medicine and his M.S. in Preventive Medicine in 1988 from the University of Maryland School of Medicine, where he also completed his residency. He is Board Certified in Public Health and General Preventive Medicine.

Top of page

Last Updated: October 1, 2012